The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation
Open accessAbstract
The aggressiveness of a tumor is partly attributed to its resistance to chemotherapeutic agent-induced apoptosis. Cysteine-rich 61 (Cyr61), from the CCN gene family, is a secreted and matrix-associated protein, which is involved in many cellular activities such as growth and differentiation. Here we established a cell model system to examine whether stable expression of Cyr61 in MCF-7 cells can confer resistance to apoptosis and identify possible participating mechanisms. We showed that stable cell lines overexpressing Cyr61 had acquired a remarkable resistance to apoptosis induced by paclitaxel, adriamycin, and β-lapachone. Most interesting, gel shift and reporter assays showed that the Cyr61-overexpressing cells had significantly increased NF-κB activity compared with neo control cells. Blockage of NF-κB activity in Cyr61-expressing cells by transfecting with a dominant negative (DN)-IκB or with an NF-κB decoy rendered them more susceptible to anti-cancer drugs-induced apoptosis. In addition, several NF-κB-regulated anti-apoptotic genes were examined, and we found that only XIAP showed a significant 3–4-fold increase in mRNA and protein in Cyr61-overexpressing cells but not in neo control cells. Treatment with inhibitor of apoptosis protein (XIAP)-specific antisense, but not sense, oligonucleotides abolished the apoptosis resistance of the Cyr61-overexpressing cells. At the same time, transfection of these stable cells with DN-IκB to block NF-κB activity also effectively reduced the elevated XIAP level. Function-neutralizing antibodies to αvβ3 and αvβ5 could inhibit Cyr61-mediated NF-κB activation as well as XIAP expression. Taken together, our data suggested that Cyr61 plays an important role in resistance to chemotherapeutic agent-induced apoptosis in human breast cancer MCF-7 cells by a mechanism involving the activation of the integrins/NF-κB/XIAP signaling pathway. The aggressiveness of a tumor is partly attributed to its resistance to chemotherapeutic agent-induced apoptosis. Cysteine-rich 61 (Cyr61), from the CCN gene family, is a secreted and matrix-associated protein, which is involved in many cellular activities such as growth and differentiation. Here we established a cell model system to examine whether stable expression of Cyr61 in MCF-7 cells can confer resistance to apoptosis and identify possible participating mechanisms. We showed that stable cell lines overexpressing Cyr61 had acquired a remarkable resistance to apoptosis induced by paclitaxel, adriamycin, and β-lapachone. Most interesting, gel shift and reporter assays showed that the Cyr61-overexpressing cells had significantly increased NF-κB activity compared with neo control cells. Blockage of NF-κB activity in Cyr61-expressing cells by transfecting with a dominant negative (DN)-IκB or with an NF-κB decoy rendered them more susceptible to anti-cancer drugs-induced apoptosis. In addition, several NF-κB-regulated anti-apoptotic genes were examined, and we found that only XIAP showed a significant 3–4-fold increase in mRNA and protein in Cyr61-overexpressing cells but not in neo control cells. Treatment with inhibitor of apoptosis protein (XIAP)-specific antisense, but not sense, oligonucleotides abolished the apoptosis resistance of the Cyr61-overexpressing cells. At the same time, transfection of these stable cells with DN-IκB to block NF-κB activity also effectively reduced the elevated XIAP level. Function-neutralizing antibodies to αvβ3 and αvβ5 could inhibit Cyr61-mediated NF-κB activation as well as XIAP expression. Taken together, our data suggested that Cyr61 plays an important role in resistance to chemotherapeutic agent-induced apoptosis in human breast cancer MCF-7 cells by a mechanism involving the activation of the integrins/NF-κB/XIAP signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CCN1 promotes the survival of endothelial cells through integrin αvβ3 [72], and inhibits apoptosis by activation of Akt in pulmonary epithelial cells [80] or upregulation of XIAP in MCF7 breast cancer cells [81].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“Although CCN1 promotes cell survival in endothelial cells and some cancer cells [72,81], it represents the first example of an ECM molecule that can induce apoptosis through the process cell adhesion [61].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“The anti-apoptotic functions of CCN1 in breast cancer cells are mediated through its receptor integrin αvβ3 [81,153], whose expression is also induced by CCN1 [154].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“In MCF7 breast cancer cells, which are dependent on estrogen for growth, overexpression of CCN1 renders these cells estrogen-independent and significantly resistant to apoptosis, in part through upregulation of the anti-apoptotic protein XIAP [81,152,153].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
In the citing paper
“In MCF7 breast cancer cells, which are dependent on estrogen for growth, overexpression of CCN1 renders these cells estrogen-independent and significantly resistant to apoptosis, in part through upregulation of the anti-apoptotic protein XIAP [81,152,153].”
From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chawla‐Sarkar, M., Bauer, J. A., Lupica, J. A., Morrison, B., Tang, Z., Oates, R. K., Almasan, A., DiDonato, J. A., Borden, E. C., & Lindner, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306111200 · Cited by 77
RetractedA multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1209 · Cited by 2,218
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,889
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,427
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S. D., Korneluk, R. G., & MacKenzie, A. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 980
Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β
Abreu, J. G., Ketpura, N. I., Reversade, B., & Robertis, E. M. D. (2002) · Nature Cell Biology · doi:10.1038/ncb826 · Cited by 901
Apoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 836
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 773
Flagged first, then by citations
Research works printed but not linked: 8
- O'Brien, 1990, Mol. Cell. Biol., 10, 3569
- Xie, 2001, Cancer Res., 61, 8917
- Romieu-Mourez, 2002, Cancer Res., 62, 6770
- Grzeszkiewicz, 2002, Endocrinology, 143, 1441, 10.1210/endo.143.4.8731 · DOI · Paper page
- Tsai, 2000, Cancer Res., 60, 5603
- Qi, 2003, Cancer Res., 63, 7076
- Kikuchi, 2003, Cancer Res., 63, 107
- Yang, 2003, Cancer Res., 63, 6815
Cited by
Sorted by citations
Items 101–196 of 196
High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma
Liu, Y., Zhang, F., Zhang, Z., Wang, D., Cui, B., Zeng, F., Huang, L., Zhang, Q., & Sun, Q. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.06.004 · Cited by 31
Looso, M., Michel, C. S., Konzer, A., Bruckskotten, M., Borchardt, T., Krüger, M., & Braun, T. W. (2012) · Journal of Proteome Research · doi:10.1021/pr300521p · Cited by 30
POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway
Weng, T., & Koh, C.-G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.443 · Cited by 29
Wang, Z., Xia, Q., Cui, J., Diao, Y., & Li, J. (2014) · Oncology Reports · doi:10.3892/or.2014.3154 · Cited by 28
Tang, Q.-L., Fan, S., Li, H., Chen, W., Shen, X., Yuan, X.-P., Chang, S., & Song, Y. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.02.022 · Cited by 28
A global genomic view of MIF knockdown-mediated cell cycle arrest
Liu, L., Ji, C., Chen, J., Li, Y., Fu, X., Xie, Y., Gu, S., & Mao, Y. (2008) · Cell Cycle · doi:10.4161/cc.7.11.6011 · Cited by 28
Lin, J., Li, N., Chen, H., Liu, C., Yang, B., & Ou, Q. (2015) · Medicine · doi:10.1097/md.0000000000000834 · Cited by 28
NF-kappaB-Dependent Apoptotic Hair Cell Death in the Auditory System
Nagy, I., Caelers, A., Monge, A., Bonabi, S., Huber, A. M., & Bodmer, D. (2007) · Audiology and Neurotology · doi:10.1159/000101328 · Cited by 27
The matrix protein CCN1/CYR61 is required for αVβ5‐mediated cancer cell migration
Jandová, J., Beyer, T. E., Meuillet, E. J., & Watts, G. S. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2853 · Cited by 26
SENP2 suppresses NF-κB activation and sensitizes breast cancer cells to doxorubicin
Gao, X., Wu, Y., Qiao, L., & Feng, X. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.051 · Cited by 26
Ibrahim, S. L., Abed, M. N., Mohamed, G. G., Price, J. C., Abdullah, M. I., & Richardson, A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02095-9 · Cited by 25
Prediction of Anticancer Drug Potency from Expression of Genes Involved in Growth Factor Signaling
Zunyan Dai, Y., Bárbácioru, C., Huang, Y. S., & Sadée, W. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9260-y · Cited by 24
Gao, R., & Brigstock, D. R. (2005) · Cell Communication and Signaling · doi:10.1186/1478-811x-3-14 · Cited by 23
Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs
Liao, W.-L., Lin, S.-C., Sun, H. S., & Tsai, S. (2014) · Biomarkers and Genomic Medicine · doi:10.1016/j.bgm.2014.01.003 · Cited by 24
Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway
Niu, C., Zhao, C., Yang, Z., Zhang, X.-L., Pan, J., Zhao, C., & Si, W. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0074-z · Cited by 22
Zhang, J., Huang, Y., Xu, J., Zhao, R., Xiong, C., Habu, J., Wang, Y., & Luo, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1033683 · Cited by 21
Ling, X., & Li, F. (2013) · Europe PMC (PubMed Central) · Cited by 21
Allen, T. D., Moore, D. R., Wang, X., Casu, V., May, R. J., Lerner, M. R., Houchen, C. W., Brackett, D. J., & Huycke, M. M. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47798-0 · Cited by 21
Gong, G., Shen, Y., Lan, H.-Y., Jin, J., An, P., Zhang, L., Chen, L., Peng, W., Luan, X., & Zhang, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6677687 · Cited by 23
Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells
Ilhan, M., Küçükköse, C., Efe, E., Günyüz, Z. E., Yildirir, B. F., Dogan, H., Özuysal, M., & Yalcin-Ozuysal, Ö. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151070 · Cited by 19
CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer
Wang, X., Deng, Y., Mao, Z., Ma, X., Fan, X., Cui, L., Qu, J., Xie, D., & Zhang, J. (2012) · Tumor Biology · doi:10.1007/s13277-012-0434-z · Cited by 20
Hermansyah, D., Putra, A. B., Munir, D., Lelo, A., Amalina, N. D., & Alif, I. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.5941 · Cited by 26
Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers
Ye, Q., Zhuang, X.-Z., Li, J., & Zhou, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1562167 · Cited by 18
Chin, L.-H., Hsu, S., Zhong, W., & Liang, Y. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22308 · Cited by 18
Huang, Z., Wang, H., & Ji, Z. (2021) · Inflammation Research · doi:10.1007/s00011-021-01494-7 · Cited by 19
Zhu, X., Song, Y., Wu, C., Pan, C., Lu, P., Wang, M., Zheng, P., Huo, R., Zhang, C., Li, W., et al. (2016) · Scientific Reports · doi:10.1038/srep34018 · Cited by 17
Xiao, G., Yang, Q., Bao, Z., Mao, H., Zhang, Y., & Lin, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07014-w · Cited by 17
Ooyama, A., Takechi, T., Toda, E., Nagase, H., Okayama, Y., Kitazato, K., Sugimoto, Y., Oka, T., & Fukushima, M. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00204.x · Cited by 17
Functions of Yes-association protein (YAP) in cancer progression and anticancer therapy resistance
Zhang, Y., Wang, X., & Zhou, X. (2022) · Brain Science Advances · doi:10.26599/bsa.2022.9050008 · Cited by 17
Ashoka, G. B., & Shivanna, M. B. (2023) · Archives of Microbiology · doi:10.1007/s00203-022-03388-6 · Cited by 16
Therapeutic potential of cysteine-rich protein 61 in rheumatoid arthritis
Xu, T., He, Y., Wang, M., Yao, H.-W., Ni, M.-M., Zhang, L., Meng, X., Huang, C., Ge, Y., & Li, J. (2016) · Gene · doi:10.1016/j.gene.2016.07.053 · Cited by 16
CCN1 sensitizes esophageal cancer cells to TRAIL-mediated apoptosis
Dang, T., Modak, C., Meng, X., Wu, J., Narvaez, R., & Chai, J. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.10.015 · Cited by 16
Expression of tumor-promoting Cyr61 is regulated by hTRA2- 1 and acidosis
Hirschfeld, M., Jaeger, M., Buratti, E., Stuani, C., Grueneisen, J. S., Gitsch, G., & Stickeler, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr128 · Cited by 17
Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
Cheng, Z., Zhang, Y., Tian, Y., Chen, Y., Ding, F., Wu, H. J., Ji, Y., & Shen, M. (2021) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00360-y · Cited by 15
Chuang, J., Yu, N., Chiang, I., Lai, C., Lin, C., & Tang, C. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24066 · Cited by 15
YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer
Huang, M. L., Wang, H., Mackey, C., Chung, M. C., Guan, J., Zheng, G., Roy, A., Xie, M., Vulpe, C. D., & Tang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512491 · Cited by 14
Greenberger, L. M., & Sampath, D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_18 · Cited by 15
CCN1 Induces β -Catenin Translocation in Esophageal Squamous Cell Carcinoma through Integrin α 11
Chai, J., Modak, C., Ouyang, Y. Q., Wu, S.-Y., & Jamal, M. M. (2012) · ISRN Gastroenterology · doi:10.5402/2012/207235 · Cited by 14
Laguillier, C., Hbibi, A. T., Baran‐Marszak, F., Metelev, V., Cao, A., Cymbalista, F., Bogdanov, A. A., Jr., & Fagard, R. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.024 · Cited by 14
CYR61 suppresses growth of human malignant melanoma
Chen, J., Liu, Y., Qilin, S., Wang, B., Li, N., & Chen, X. (2016) · Oncology Reports · doi:10.3892/or.2016.5124 · Cited by 13
The Role of CCN1 in Esophageal Adenocarcinoma: What We Have Learned From the Lab
Chang, Z., Dang, T., Meng, X., & Chai, J. (2022) · Cancer Control · doi:10.1177/10732748221074734 · Cited by 12
Song, Q., Wang, G., Chu, Y., Zhou, L., Jiang, M., He, Q., Liu, M., Qin, J., & Hu, J. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.03.034 · Cited by 12
Baek, E. H., Lee, J. S., & Lee, G. M. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26777 · Cited by 12
Targeted molecular therapy in peripheral T-cell lymphomas
Roncolato, F., Gazzola, A., Zinzani, P. L., Pileri, S. A., Piccaluga, P. P., & for the European T-cell Lymphoma Study Group (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.55 · Cited by 11
Marxfeld, H., Staedtler, F., & Harleman, J. H. (2006) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2006.05.003 · Cited by 11
Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer
Shi, W., Zhang, C., Chen, Z., Chen, H. H., Liu, L., & Meng, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.12248 · Cited by 10
Cyr61 mediates oxaliplatin resistance in colorectal cancer cells by regulating Bcl-xL expression
Song, Y., Kang, Y., Lin, Z., Zeng, M., Shi, P., Lin, J., Lu, P., Luo, L., Cao, Y., & Zhu, X. (2021) · Journal of Cancer · doi:10.7150/jca.48891 · Cited by 10
Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer
Singh, S. K. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073269599231009115338 · Cited by 9
Song, Y., Lin, Q., Cai, Z., Hao, T., Zhang, Y., & Zhu, X. (2019) · Cancer Science · doi:10.1111/cas.14083 · Cited by 9
Rabi, T., & Li, F. (2018) · Europe PMC (PubMed Central) · Cited by 9
Bartel, F., Balschun, K., Gradhand, E., Strauß, H. G., Dittmer, J., & Hauptmann, S. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31824d1891 · Cited by 9
A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk
Tao, L., Chen, J., Zhou, H., Qin, C., Li, P., Cao, Q., Li, J., Ju, X., Zhu, C., Wang, M., et al. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.41 · Cited by 10
Chovolou, Y., Wätjen, W., Kampkötter, A., & Kahl, R. (2006) · Toxicology · doi:10.1016/j.tox.2006.12.012 · Cited by 9
Developing curcumin into a viable therapeutic for lymphoma
Shahab Uddin, M. S., Khan, A. S., & Al-Kuraya, K. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802594593 · Cited by 8
Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice
Hsu, P., & Mo, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9162 · Cited by 8
Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer
Wang, Y., & Wang, M. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0478-4 · Cited by 8
Kowalczyk, A., Kasprzak, A., Popławska, M., Ruzycka-Ayoush, M., Grudziński, I. P., & Nowicka, A. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165832 · Cited by 8
Cao, Y., Wu, C., Song, Y., Lin, Z., Kang, Y., Lu, P., Zhang, C., Huang, Q., Hao, T., Zhu, X., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4018 · Cited by 7
Cui, X. Y., Chang, Z., Dang, T., Meng, J., Wang, P., Wu, J., & Chai, J. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109192 · Cited by 7
Wang, J., Fu, D., Senouthai, S., Jiang, Y., Hu, R., & You, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/8697257 · Cited by 7
Potential Role of Cyr61 Induced Degeneration of Human Müller Cells in Diabetic Retinopathy
Zhou, F., Zhang, Y., Chen, D., Su, Z., Jin, L., Wang, L., Hu, Z., Ke, Z., & Song, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109418 · Cited by 6
WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade
Yu, X., Mao, R., Feng, W., Zhao, Y., Qin, J., Yang, Y., Wang, A., & Shi, Z. Q. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112871 · Cited by 6
Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma
Zaidi, A. R. S., Dresman, S., Burt, C., Rule, S. A., & McCallum, L. M. R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0494-y · Cited by 5
Bioactive Natural Products for Breast Cancer Chemoprevention and Treatment
Mokashi, A., & Bhatia, N. M. (2023) · Current Bioactive Compounds · doi:10.2174/1573407219666230529151351 · Cited by 5
The Inhibition of Hsp27 Chaperone Affects the Level of p53 Protein in Tumor Cells
Кайгородова, Е. В., Litvinova, L. S., Коновалова, Е. В., Klimova, M. V., Таширева, Л. А., Nosareva, O. L., & Novitskiy, V. V. (2013) · International Journal of Biology · doi:10.5539/ijb.v5n3p13 · Cited by 5
Wang, P., Chang, Z., Meng, J., Cui, X., Chai, J., & Dang, T. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110374 · Cited by 5
Department of Pathology and Molecular Medicine
Kodet, R. (2009) · Cited by 5
CCN1 : A Dermo‐Epidermal Crosstalk Mediator and Regulatory Protein in Cutaneous Homeostasis
Wu, Y., Lin, Y., Li, L., Guo, M., Wu, Y., & Yi, F. (2025) · Experimental Dermatology · doi:10.1111/exd.70157 · Cited by 5
CCN1 is critical for acid-induced esophageal epithelial cell transformation
Modak, C., Mouazzen, W., Narvaez, R., Reavis, K. M., & Chai, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.057 · Cited by 4
Molecular Profiling of Aggressive Lymphomas
Rossi, M., Laginestra, M. A., Gazzola, A., Sapienza, M. R., Pileri, S. A., & Piccaluga, P. P. (2011) · Advances in Hematology · doi:10.1155/2012/464680 · Cited by 4
Pan, K., Li, X., He, J., Lei, Y., Yang, Y., Jiang, D., & Tang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-023-49156-4 · Cited by 3
Shi, P., Lin, Z., Song, Y., Li, Z., Zeng, M., Luo, L., Cao, Y., & Zhu, X. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05692-8 · Cited by 3
Molecular basis for the recognition of CCN1 by monoclonal antibody 093G9
Zhong, C., Huo, R., Hu, K., Shen, J., Li, D., Li, N., & Ding, J. (2017) · Journal of Molecular Recognition · doi:10.1002/jmr.2645 · Cited by 3
Xu, R., Jiang, Z., Meng, X., Xing, L., Aladan, W., Chi, B., Dang, T., & Chai, J. (2024) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.12046 · Cited by 2
Vitale, G., Gentilini, D., Abbruzzese, A., & Caraglia, M. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.3.7616 · Cited by 2
Gene expression profiling of peripheral T-cell lymphoma: from bench to bedside
Piccaluga, P. P., Rossi, M., Gazzola, A., Sapienza, M. R., Mannu, C., Righi, S., Agostinelli, C., Sista, M. T., & Pileri, S. A. (2009) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · doi:10.4081/hmr.v3i1.528 · Cited by 1
Molecular Profiling of Peripheral T-Cell Lymphomas
Piccaluga, P. P., & Pileri, S. A. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-408-1_3 · Cited by 1
Aird, K. M. (2010) · DukeSpace (Duke University) · Cited by 1
Schütze, N., Wagemanns, R., Schilling, T., & Jakob, F. J. (2006) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003362.01 · Cited by 1
Molecular Profiling and Prognosis in T-Cell Lymphomas
Piccaluga, P. P., & Pileri, S. A. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-170-7_3
Effects of reduced frequency of milk removal on gene expression in the bovine
Littlejohn, M. D., Walker, C. G., Ward, H. E., Lehnert, K., Snell, R. G., Verkerk, G. A., Spelman, R. J., Clark, D. A., & Davis, S. R. (2009)
expression in the bovine mammary gland Effects of reduced frequency of milk removal on gene
Spelman, R. J., Clark, D. A., Davis, S. R., Littlejohn, M. D., Walker, C. G., Ward, H. E., Houdayer, C., & Snell, R. G. (2015)
Direktor, Ä., & Autenrieth, I. B. (2008)
The inhibition of mammary epithelial cell growth by the long isoform of Angiomotin
Adler, J. J. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1875
Schattner, E. J., Furman, R. R., & Bernal, A. (2007) · Springer eBooks · doi:10.1007/0-387-33573-0_10
İlhan, M. (2017) · İYTE (İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ)
HBXIP contributes to radioresistance through NF-κB-mediated expression of XIAP in breast cancer
Chu, X., Zheng, W., Chen, Q., Wang, C., Fan, S., & Shao, C. (2021) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2021.04.003
Vijayalekha, A., Sivaprakasam, P., Anandasadagopan, S. K., Pandurangan, A. K., & Alagumuthu, T. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-9258-8.ch001
Additional file 2 of TRIM proteins in hepatocellular carcinoma
Lu, K., Pan, Y., Huang, Z., Liang, H., Ding, Z., & Zhang, B. (2022) · Figshare · doi:10.6084/m9.figshare.21102178
Additional file 1 of Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
Cheng, Z., Zhang, Y., Tian, Y., Chen, Y., Ding, F., Wu, H. J., Ji, Y., & Shen, M. (2021) · Figshare · doi:10.6084/m9.figshare.14385682
Li, Z. (2024) · American Journal of Cancer Research · doi:10.62347/ckmt4065
CYR61 as a Potential Apoptosis Biomarker in Osteoarthritis with Comorbidities.
Tokuş, M., Çıçek, H., Ates, H., Coşkun, Ç., Döğüş, Y., & Çiçek, F. A. (2024) · PubMed Central
Additional file 3 of TRIM proteins in hepatocellular carcinoma
Lu, K., Pan, Y., Huang, Z., Liang, H., Ding, Z.-Y., & Zhang, B. (2022) · Figshare · doi:10.6084/m9.figshare.21102181
Additional file 1 of TRIM proteins in hepatocellular carcinoma
Lu, K., Pan, Y., Huang, Z., Liang, H., Ding, Z.-Y., & Zhang, B. (2022) · Figshare · doi:10.6084/m9.figshare.21102172
Additional file 2 of Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
Cheng, Z., Zhang, Y., Tian, Y., Chen, Y., Ding, F., Wu, H., Ji, Y., & Shen, M. (2021) · Figshare · doi:10.6084/m9.figshare.14385685
Zhang, Y., Tian, H., Wang, S., Lin, F., Li, W., Jiang, R., Jiang, Z., & Wang, W. (2026) · Cancer Medicine · doi:10.1002/cam4.72352
Metadata
- Authors
- Lin, M.-T., Chang, C.-C., Chen, S.-T., Chang, H.-L., Su, J.-L., Chau, Y.-P., & Kuo, M.-L.
- Affiliations
- National Taiwan University Hospital (TW)
- National Taiwan University (TW)
- National Health Research Institutes (TW)
- National Yang Ming University (TW)
- Corresponding author
- Kuo, Min-Liang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 23
- Pages
- 24015-24023
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1983777512
- Cited by
- 194
- References
- 86
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 12 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 8 · 2014: 8 · 2013: 9 · 2012: 11
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Science Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CYR61, CCN family, apoptosis resistance, breast cancer, MCF-7 cells, NF-κB, XIAP, chemoresistance, integrins, integrin αvβ3, paclitaxel, doxorubicin, β-lapachone, antisense oligonucleotides, anti-apoptotic genes
- MeSH terms
- Antibiotics, Antineoplastic, Antineoplastic Agents, Phytogenic, Breast Neoplasms, Cell Division, Cell Nucleus, Cell Survival, DNA, Doxorubicin, Flow Cytometry, Genes, Dominant, Humans, Microscopy, Fluorescence, Models, Biological, Naphthoquinones, Promoter Regions, Genetic, Proteins, RNA, Messenger, Time Factors, Transfection, Blotting, Western, Signal Transduction, Up-Regulation, Integrins, NF-kappa B, Oligonucleotides, Antisense, Apoptosis, Paclitaxel, Immediate-Early Proteins, Genes, Reporter, Receptors, Vitronectin, Reverse Transcriptase Polymerase Chain Reaction, Active Transport, Cell Nucleus, Intercellular Signaling Peptides and Proteins, Integrin alphaVbeta3, Cell Line, Tumor, X-Linked Inhibitor of Apoptosis Protein, Cysteine-Rich Protein 61
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
